Ua hui pū ʻia ʻo SARS-CoV-2, ka Influenza A&B Antigen, ka Respiratory Syncytium, Adenovirus a me Mycoplasma Pneumoniae

Ua hui pū ʻia ʻo SARS-CoV-2, Influenza A&B Antigen, Respiratory Syncytium, Adenovirus a me Mycoplasma Pneumoniae Kiʻi i Hōʻike ʻia

Wehewehe Pōkole:

Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka antigen influenza A&B, ka Respiratory Syncytium, adenovirus a me ka mycoplasma pneumoniae i loko o ka swab nasopharyngeal, ka swab oropharyngeal a me nā laʻana swab nasal in vitro, a hiki ke hoʻohana ʻia no ka ʻike ʻokoʻa o ka maʻi coronavirus hou, ka maʻi respiratory syncytial virus, adenovirus, mycoplasma pneumoniae a me ka maʻi influenza A a i ʻole B. No ka ʻike lapaʻau wale nō nā hopena hoʻāʻo, ʻaʻole hiki ke hoʻohana ʻia ma ke ʻano he kumu wale nō no ka ʻike a me ka mālama ʻana.

E leka uila mai iā mākou

Nā kikoʻī huahana

Nā Lepili Huahana

Inoa huahana

HWTS-RT170 SARS-CoV-2, Influenza A&B Antigen, Respiratory Syncytium, Adenovirus a me Mycoplasma Pneumoniae i hui pū ʻia me ka pahu ʻike (Latex Method)

Palapala hōʻoia

ʻAlapia

ʻO ka maʻi coronavirus hou (2019, COVID-19), i kapa ʻia ʻo "COVID-19", pili i ka maʻi niumonia i hoʻokumu ʻia e ka maʻi coronavirus hou (SARS-CoV-2).

ʻO ka maʻi syncytial respiratory (RSV) kahi kumu maʻamau o nā maʻi ʻōpū hanu o luna a me lalo, a ʻo ia ke kumu nui o ka bronchiolitis a me ka pneumonia i nā pēpē.

ʻO ka maʻi palū, i kapa ʻia ʻo influenza no ka pōkole, no ka Orthomyxoviridae a he maʻi RNA kaula maikaʻi ʻole i māhele ʻia.

No ka ʻohana adenovirus ka adenovirus mammalian, he maʻi DNA kaula pālua ia me ka ʻole o kahi envelope.

ʻO Mycoplasma pneumoniae (MP) ka microorganism ʻano cell prokaryotic liʻiliʻi loa me ke ʻano cell akā ʻaʻohe paia cell, kahi ma waena o nā bacteria a me nā virus.

Nā Palena ʻenehana

ʻĀpana i manaʻo ʻia	SARS-CoV-2, ka antigen influenza A&B, ka Respiratory Syncytium, adenovirus, mycoplasma pneumoniae
Mahana mālama	4℃-30℃
ʻAno laʻana	ʻUlu nasopharyngeal, ʻUlu oropharyngeal, ʻUlu ihu
Ola papa	24 mahina
Nā mea hana kōkua	ʻAʻole koi ʻia
Nā Mea Hoʻopau Keu	ʻAʻole koi ʻia
Ka manawa ʻike	15-20 minuke
Kūlana kikoʻī	ʻAʻohe cross-reactivity me 2019-nCoV, human coronavirus (HCoV-OC43, HCoV-229E, HCoV-HKU1, HCoV-NL63), MERS coronavirus, novel influenza A H1N1 virus (2009), seasonal H1N1 influenza virus, H3N2, H5N1, H7N9, influenza B Yamagata, Victoria, adenovirus 1-6, 55, parainfluenza virus 1, 2, 3, rhinovirus A, B, C, human metapneumovirus, intestinal virus groups A, B, C, D, epstein-barr virus, measles virus, human cytomegalovirus, rotavirus, norovirus, mumps virus, varicella-zoster virus, mycoplasma pneumoniae, chlamydia pneumoniae, haemophilus influenzae, staphylococcus aureus, streptococcus pneumoniae, klebsiella pneumoniae, mycobacterium tuberculosis, candida albicans pathogens.

Kahe Hana

●Koko venous (Serum, Plasma, a i ʻole ke koko holoʻokoʻa)

●E heluhelu i ka hopena (15-20 mau minuke)

Nā Mālama:
1. Mai heluhelu i ka hopena ma hope o 20 mau minuke.
2. Ma hope o ka wehe ʻana, e ʻoluʻolu e hoʻohana i ka huahana i loko o 1 hola.
3. E ʻoluʻolu e hoʻohui i nā laʻana a me nā buffers e like me nā kuhikuhi.

Ma mua: Mea Hoʻokaʻawale Waikawa Nucleic Macro & Micro-Test

Aʻe: ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou